Interna Therapeutics, a clinical-stage biopharmaceutical company announced today that it has signed an agreement with the University of Oxford to conduct a Phase IIa human challenge trial evaluating ...

Objectives This study aims to estimate the prevalence of long-lasting severe fatigue and identify possible risk factors in a 2-year follow-up of patients with predominantly mild-to-moderate SARS-CoV-2 ...

A large population-based study from the British Columbia Centre for Disease Control, published in Diabetes/Metabolism ...

Nearly three years since the SARS-CoV-2 pandemic was declared over, conservative estimates suggest that between 80 million ...

Lung function may shape COVID-19 outcomes in cystic fibrosis transplant recipients. Learn more about the latest findings and ...

COVID-19 infection, compared with influenza, was associated with significantly greater risks for developing AKI, chronic ...

Four years after infection with the wild-type SARS-CoV-2 strain, up to 60% of health care workers (HCWs) in Switzerland still ...

The highly mutated SARS-CoV-2 BA.3.2 variant, which has been reported by at least 23 countries as of February 11, has been ...

Severe COVID-19 and influenza infections can epigenetically reprogram lung and immune cells, creating a pro‑tumor environment ...

What is the impact of a viral infection on our memory, attention, or concentration? The Covid-19 pandemic has revived ...